AdaptHealth Corp. (NASDAQ:AHCO) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

AdaptHealth Corp. (NASDAQ:AHCO) has been assigned an average rating of “Moderate Buy” from the seven research firms that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $13.60.

AHCO has been the subject of several research reports. Zacks Research upgraded shares of AdaptHealth from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st. Canaccord Genuity Group raised their target price on shares of AdaptHealth from $14.00 to $15.00 and gave the stock a “buy” rating in a report on Thursday, November 6th. Weiss Ratings raised shares of AdaptHealth from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, December 29th. Finally, Wall Street Zen downgraded AdaptHealth from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 8th.

Insider Buying and Selling

In related news, Director David Solomon Williams III sold 5,000 shares of AdaptHealth stock in a transaction that occurred on Thursday, December 4th. The stock was sold at an average price of $9.43, for a total transaction of $47,150.00. Following the completion of the transaction, the director directly owned 45,045 shares in the company, valued at approximately $424,774.35. This trade represents a 9.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.55% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On AdaptHealth

Hedge funds and other institutional investors have recently made changes to their positions in the company. FNY Investment Advisers LLC purchased a new position in shares of AdaptHealth during the 3rd quarter valued at approximately $35,000. AlphaQuest LLC grew its position in AdaptHealth by 275.7% during the second quarter. AlphaQuest LLC now owns 3,941 shares of the company’s stock valued at $37,000 after buying an additional 2,892 shares during the period. Assetmark Inc. raised its position in shares of AdaptHealth by 87.6% in the second quarter. Assetmark Inc. now owns 5,529 shares of the company’s stock worth $52,000 after acquiring an additional 2,581 shares during the period. Tower Research Capital LLC TRC raised its position in shares of AdaptHealth by 318.0% in the second quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after acquiring an additional 7,297 shares during the period. Finally, Tidal Investments LLC purchased a new stake in shares of AdaptHealth during the 2nd quarter worth about $96,000. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Stock Up 1.1%

AdaptHealth stock opened at $9.78 on Tuesday. The business’s 50-day simple moving average is $9.73 and its two-hundred day simple moving average is $9.40. The company has a debt-to-equity ratio of 1.09, a quick ratio of 0.86 and a current ratio of 1.08. The company has a market cap of $1.32 billion, a PE ratio of 17.78, a PEG ratio of 1.10 and a beta of 1.71. AdaptHealth has a fifty-two week low of $7.11 and a fifty-two week high of $11.63.

AdaptHealth (NASDAQ:AHCO) last released its earnings results on Tuesday, November 4th. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.05). The firm had revenue of $820.31 million for the quarter, compared to analyst estimates of $799.62 million. AdaptHealth had a return on equity of 4.85% and a net margin of 2.53%.The company’s revenue for the quarter was up 1.8% compared to the same quarter last year. During the same period last year, the firm earned $0.15 EPS. Equities analysts anticipate that AdaptHealth will post 0.88 EPS for the current year.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.